Jo is an experienced and successful investment professional with more than 10 years in the private equity industry. A qualified accountant, ACA, by training, she has worked in the corporate finance departments of FTSE 100 and FTSE 250 companies.
Simon joined the Institute as a tenure-track group leader in 1997 and held a CRUK Senior Cancer Research Fellowship from 2000-2006.
Karen studied for a degree in biology and PhD in microbiology. Before joining BBSRC, she worked in commercial research and development with both a small biotechnology company and a large corporate.
Jane was an early employee of Cambridge Antibody Technology (CAT), which became MedImmune, the global biologics research and development arm of AstraZeneca.
Derek is Chief Executive of Babraham Research Campus Ltd (formerly Babraham Bioscience Technologies Ltd (BBT)), the company which manages and develops the Babraham Research Campus.
Becky is Chief Financial Officer. Having joined Babraham Research Campus Ltd (formerly BBT) in 2002, Becky is responsible for the finance, HR and health & safety functions of Babraham Research Campus Ltd.
Clive is an independent cancer drug discovery and development advisor. In addition to the Babraham Research Campus, Clive holds non-executive director positions at Atelerix Ltd and CytoSeek Ltd and serves on the scientific advisory boards of 4Bio Capital and ANGLE plc.
Alex is a highly experienced Chartered Engineer and Chartered Surveyor with over 20 years’ experience working in a variety of environments successfully delivering business critical projects and programmes; the last 13 years of which have been specialising within the life-sciences sector.